France begins trials of new COVID vaccine
Other countries
- 25 February, 2021
- 06:11
French biotechnology company Xenothera has begun clinical trials of its coronavirus vaccine, Report informs with reference to TASS.
The vaccine is named Xav-19.
The vaccine testing program follows Polycor standards, one of 15 types of clinical trials of drugs approved by the French medical authorities. The trial will be carried out in 40 hospitals in the country, coordinated by the University Hospital of Nantes.
The drug will be tested on 400 volunteer patients. Currently, 67 patients from 21 hospitals are participating in the trial.
The tests are supposed to determine the level of vaccine effectiveness with great accuracy.
Latest News
20:57
Leyla Aliyeva meets with Afghan women's rights activist Zarqa Yaftali in Abu Dhabi
Foreign policy20:49
Simonyan denies shift in Armenia's foreign policy at expense of ties with Russia
Region20:16
Fitch assesses SOCAR ratings alongside 10 of world's largest oil and gas companies
Energy20:10
Photo
Azerbaijan's contribution to intercultural dialogue discussed in UN
Cultural policy19:53
Photo
Director of Heydar Aliyev School in Kahramanmaras thanks Azerbaijan for support
Region19:29
Trump says Ilham Aliyev and Pashinyan are 'two really good leaders'
Other countries19:17
Trump says US ramping up oil production to unprecedented levels
Other countries19:03
Media: Russia, US agree to observe new START terms for another six months
Other countries18:52